Immune responses to varicella-zoster virus.
The host response to VZV is critical to the outcome of primary VZV infection. The maintenance of immune memory to the virus is required to prevent symptomatic re-infection on exogenous re-exposure to VZV and to prevent symptomatic reactivation of endogenous virus. Immunization with live varicella (Oka) vaccine elicits primary and memory immunity to VZV. Humoral and cell-mediated host responses induced by the wild-type virus and by the vaccine strain are comparable, which is consistent with the clinical observation that varicella vaccine protects against or significantly reduces the clinical symptoms caused by primary VZV infection. Widespread use of the varicella vaccine in healthy children will yield further knowledge about host-virus interactions, such as the role of exogenous re-exposure in maintaining persistent immunity, which will be relevant to vaccine strategies to prevent other human herpesvirus infections.
Arvin
A M
AM
Department of Pediatrics and Microbiology/Immunology, Stanford University School of Medicine, California, USA.
D000367:Age Factors; D000917:Antibody Formation; D002644:Chickenpox / Q000276:immunology / Q000821:virology; D019433:Chickenpox Vaccine / Q000008:administration & dosage / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D004198:Disease Susceptibility / Q000276:immunology; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D016867:Immunocompromised Host / Q000276:immunology; D007223:Infant; D012008:Recurrence; D014764:Viral Proteins / Q000276:immunology
D019433:Chickenpox Vaccine; D014764:Viral Proteins